CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.
CellFE has raised $1.2M in total funding. The most recent round was Grant. The last funding was announced in January 2025.
CellFE's investors include Khosla Ventures, Cota Capital, Creative Destruction Lab, GreatPoint Ventures, SkyDeck Berkeley.
CellFE is headquartered in Alameda, United States.
CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.
CellFE is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CellFE — Funding & Investors." VCBacked, January 30, 2025, https://www.vcbacked.co/company/cellfe. Accessed September 30, 2026.
VCBacked. (2025). CellFE — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cellfe
{{cite web |title=CellFE — Funding & Investors |url=https://www.vcbacked.co/company/cellfe |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated